What is the Nureca Ltd share price today?

The share price of NSE:NURECA-BE on 07 Sep 2026 (as of 10:59:55 IST) is ₹315.00.

What is the NSE:NURECA-BE 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:NURECA-BE 52 week high low range shows a high of ₹358.00 and a low of ₹204.00.

What is the Nureca Ltd market cap?

As on 07 Sep 2026, Nureca Ltd market cap is ₹310.11 Cr.

What is the shareholding pattern of Nureca Ltd Stock?

The shareholding pattern of Nureca Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 68.09% Foreign Institutional Investors (FII): 0.11% Domestic Institutional Investors (DII): 0.20% Mutual Funds: 0% Retail & Others: 31.60% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Nureca Ltd?

The Price-to-Earnings (PE) ratio of Nureca Ltd is 71.50, and the Price-to-Book (PB) ratio is 1.09, as on 07 Sep 2026.

Nureca Share Price

342.35+6.75 (+2.01%)

+45.22% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+2.01%

1 Week

-1.04%

1 Month

+15.41%

3 Month

+42.47%

6 Month

+58.31%

YTD

+11.17%

1 Year

+45.22%

5 Year

-79.39%

10 Year

Max

-44.33%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

336.00

333.20

295.00

224.02

204.00

High

346.00

355.00

358.00

About

Nureca Limited is a B2C company engaged in the business of home healthcare and wellness products, which offers quality, durability, functionality, usability and innovative designs. It enables its customers with Read more

Medical Equipment/Supplies/Accessories

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

LENSKARTNSE

POLYMEDNSE

MOLBIONSE

QLINE-SMNSE

3BBLACKBIONSE

LAXMIDENTLNSE

OSELDEVICE-SMNSE

YASHOPTICS-SMNSE

NURECA-BENSE

AVIENCE-SMNSE

LTP

1W Low

1W High

Market cap (₹)

676-31.2 (-4.41%)

669.30

698.30

1,19,386Cr

1716-10 (-0.58%)

1695.10

1772

17,504Cr

1246.2-42.1 (-3.27%)

1205.40

1338.30

15,101Cr

670-26.95 (-3.87%)

662

710

1,632Cr

1406+86.7 (6.57%)

1306.30

1440

1,230Cr

196.26-1.69 (-0.85%)

192.03

201.59

1,077Cr

390.85+26.95 (7.41%)

349.75

411

720Cr

131-2.9 (-2.17%)

130

137

333Cr

342.35-3.6 (-1.04%)

333.20

355

324Cr

340-2.4 (-0.70%)

321

379.50

194Cr

Nureca Share Price

342.35+6.75 (+2.01%)

+45.22% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-7%

3 years10%

Last year34%

Compounded Profit Growth

10 years-

5 years-46%

3 years-

Last year146%

Stock Price CAGR

10 years-

5 years-27%

3 years-1%

1 year42%

Return on Equity

10 years80%

5 years4%

3 years0%

Last year1%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-7%	10%	34%
-	-46%	-	146%
-	-27%	-1%	42%
80%	4%	0%	1%

Peer Comparison

Symbol

LENSKART

POLYMED

MOLBIO

QLINE-SM

3BBLACKBIO

LAXMIDENTL

OSELDEVICE-SM

YASHOPTICS-SM

NURECA-BE

AVIENCE-SM

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
676	₹119386 Cr	182.17	1.28	10.18	₹494 Cr
1,716	₹17504 Cr	55.55	8.49	43.73	₹322 Cr
1,246.2	₹15101 Cr	90.65	5.21	19.98	₹167 Cr
670	₹1632 Cr	29.29	21.76	28.51	₹56 Cr
1,406	₹1230 Cr	22.16	11.13	71.91	₹60 Cr
196.26	₹1077 Cr	34.86	1.87	8.63	₹29 Cr
390.85	₹720 Cr	24.62	7.93	17.14	₹29 Cr
131	₹333 Cr	36.86	—	4.71	₹9 Cr
342.35	₹324 Cr	74.76	3.21	6.74	₹2 Cr
340	₹194 Cr	22.21	7.92	18.19	₹9 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
—	—	—	—	—	—	—	—	—
₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹1 L	₹1 L	₹1 L
₹0	₹0	₹0	₹0	₹0	₹0	₹1 Cr	₹99 L	₹99 L
₹171 Cr	₹184 Cr	₹183 Cr	₹185 Cr	₹193 Cr	₹153 Cr	₹14 Cr	₹7 Cr	₹72 L
₹171 Cr	₹184 Cr	₹183 Cr	₹185 Cr	₹193 Cr	₹153 Cr	₹14 Cr	₹7 Cr	₹72 L
₹181 Cr	₹194 Cr	₹193 Cr	₹195 Cr	₹203 Cr	₹163 Cr	₹15 Cr	₹8 Cr	₹2 Cr
₹22 L	₹1 Cr	₹33 L	₹0	₹0	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹78 L	₹9 Cr	₹26 L	₹0
-₹3 Cr	-₹3 Cr	-₹5 Cr	-₹3 Cr	-₹10 L	-₹55 L	-₹4 L	-₹90,000	-₹20,000
₹61 L	₹2 Cr	₹1 Cr	₹2 Cr	₹3 Cr	₹3 Cr	₹0	₹0	₹0
₹79 L	₹70 L	₹98 L	₹79 L	₹41 L	₹45 L	₹10 L	₹3 L	₹70,000
-₹92 L	-₹18 L	-₹2 Cr	₹9 L	₹4 Cr	₹3 Cr	₹9 Cr	₹28 L	₹50,000
—	—	—	—	—	—	—	—	—
₹5 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹9 Cr	₹6 Cr	₹10 Cr	₹5 Cr
₹8 Cr	₹5 Cr	₹3 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹1 Cr	₹6 Cr	₹2 L
₹5 L	₹85 L	₹8 L	₹8 L	₹8 L	₹22 L	₹8 L	₹0	₹0
₹1 Cr	₹31 L	₹1 Cr	₹30 L	₹35 Cr	₹10 Cr	₹2 Cr	₹2 L	₹60,000
₹14 Cr	₹12 Cr	₹9 Cr	₹9 Cr	₹45 Cr	₹24 Cr	₹10 Cr	₹15 Cr	₹5 Cr
₹194 Cr	₹207 Cr	₹200 Cr	₹204 Cr	₹252 Cr	₹190 Cr	₹34 Cr	₹24 Cr	₹7 Cr
₹5 Cr	₹2 L	₹2 L	₹2 L	₹0	₹0	₹0	₹0	₹0
₹72 L	₹2 Cr	₹48 L	₹8 L	₹8 L	₹1 Cr	₹10 Cr	₹43 L	₹0
—	—	—	—	—	—	—	—	—
₹21 Cr	₹14 Cr	₹10 Cr	₹11 Cr	₹12 Cr	₹4 Cr	₹1 Cr	₹61 L	₹3 L
₹7 Cr	₹5 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹20 L	₹8 L	₹6 L	₹60,000
₹14 Cr	₹9 Cr	₹7 Cr	₹9 Cr	₹10 Cr	₹4 Cr	₹1 Cr	₹54 L	₹2 L
₹0	₹0	₹27 L	₹0	₹0	₹0	₹0	₹0	₹0
₹88 L	₹4 Cr	₹29 L	₹1 Cr	₹27 L	₹10 L	₹3 L	₹20,000	₹20,000
₹64 Cr	₹4 Cr	₹0	₹7 Cr	₹2 Cr	₹0	₹0	₹0	₹0
₹79 Cr	₹17 Cr	₹8 Cr	₹17 Cr	₹13 Cr	₹4 Cr	₹1 Cr	₹55 L	₹2 L
—	—	—	—	—	—	—	—	—
₹1 Cr	₹1 Cr	₹94 Cr	₹59 Cr	₹33 Cr	₹0	₹0	₹0	₹0
₹48 Cr	₹40 Cr	₹31 Cr	₹34 Cr	₹63 Cr	₹37 Cr	₹16 Cr	₹14 Cr	₹4 Cr
₹8 Cr	₹3 Cr	₹2 Cr	₹4 Cr	₹3 Cr	₹22 L	₹13 Cr	₹9 Cr	₹2 Cr
₹41 Cr	₹127 Cr	₹45 Cr	₹71 Cr	₹84 Cr	₹127 Cr	₹7 L	₹11 L	₹7 L
₹2 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹8 Cr	₹7 Cr	₹2 Cr	₹60,000	₹1 Cr
₹15 Cr	₹16 Cr	₹17 Cr	₹14 Cr	₹48 Cr	₹16 Cr	₹1 Cr	₹45 L	₹21 L
₹115 Cr	₹190 Cr	₹193 Cr	₹187 Cr	₹239 Cr	₹186 Cr	₹33 Cr	₹23 Cr	₹7 Cr
₹101 Cr	₹178 Cr	₹183 Cr	₹178 Cr	₹194 Cr	₹162 Cr	₹23 Cr	₹8 Cr	₹2 Cr
₹194 Cr	₹207 Cr	₹200 Cr	₹204 Cr	₹252 Cr	₹190 Cr	₹34 Cr	₹24 Cr	₹7 Cr
₹189	₹194	₹193	₹195	₹203	₹163	₹13,935	₹6,955	₹730
₹189	₹194	₹193	₹195	₹203	₹163	₹1,991	₹994	₹104

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
₹5 Cr	₹1 Cr	-₹3 Cr	-₹11 Cr	₹61 Cr	₹62 Cr	₹9 Cr	₹9 Cr	₹4 Cr
₹5 Cr	-₹9 Cr	-₹7 Cr	-₹3 Cr	-₹4 Cr	₹11 L	₹1 Cr	₹30 L	₹3 L
-₹7 Cr	-₹10 Cr	₹5 Cr	₹29 Cr	-₹38 Cr	-₹13 Cr	-₹18 Cr	-₹9 Cr	-₹4 Cr
₹3 Cr	-₹18 Cr	-₹4 Cr	₹14 Cr	₹19 Cr	₹50 Cr	-₹8 Cr	₹31 L	₹10 L
₹3 Cr	-₹19 Cr	-₹3 Cr	₹10 Cr	₹1 Cr	₹35 Cr	-₹8 Cr	₹31 L	₹10 L
₹14 Cr	₹8 Cr	₹18 Cr	-₹16 Cr	-₹3 Cr	-₹110 Cr	-₹39 L	-₹12 L	-₹2 L
-₹20 Cr	-₹17 L	-₹1 Cr	-₹2 Cr	-₹7 Cr	₹92 Cr	₹8 Cr	-₹14 L	-₹6 L
-₹2 Cr	-₹11 Cr	₹14 Cr	-₹8 Cr	-₹9 Cr	₹17 Cr	-₹4 L	₹4 L	₹2 L
₹3 Cr	₹14 Cr	₹50 L	₹8 Cr	₹17 Cr	₹7 L	₹11 L	₹7 L	₹5 L
-₹70,000	-₹80,000	-₹30,000	-₹90,000	-₹10,000	₹20,000	₹40,000	-₹10,000	₹0
₹1 Cr	₹3 Cr	₹14 Cr	₹50 L	₹8 Cr	₹17 Cr	₹7 L	₹11 L	₹7 L

Fundamental Ratios

Consolidated

Standalone

Nureca Share Price

342.35+6.75 (+2.01%)

+45.22% past 1 Year

Shareholding summary

Promoters

68.09%

FII

0.11%

DII

0.2%

Others

31.6%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
68.09%	68.09%	68.09%	64.97%	64.33%	64.30%
0.11%	0.28%	0.09%	0.07%	0.07%	1.07%
0.20%	0.20%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
31.60%	31.43%	31.82%	34.96%	35.60%	34.63%

Bulk & block deals

Name

Swathitha Sivakumar

Copthall Mauritius Investment Limited

Aakraya Research Llp

Elixir Wealth Management Private Limited

N V Investments

Mudupulavemula Surendranadha Reddy

Nk Securities Research Private Limited

Elixir Wealth Management Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
29 Oct 2025	Sell	2.05 Cr	₹263.96	77.76 K	Bulk	0.777594	NSE
15 Jan 2025	Purchase	4.69 Cr	₹401.94	1.17 L	Bulk	1.167087	NSE
15 Jan 2025	Purchase	2.62 Cr	₹409.49	63.94 K	Bulk	0.639357	NSE
15 Jan 2025	Sell	2.62 Cr	₹409.84	63.94 K	Bulk	0.639357	NSE
14 Jan 2025	Purchase	1.86 Cr	₹360.28	51.68 K	Bulk	0.51678	NSE
14 Jan 2025	Sell	2.39 Cr	₹363.99	65.68 K	Bulk	0.656777	NSE
10 Jan 2025	Purchase	5.67 Cr	₹358.81	1.58 L	Bulk	1.579968	NSE
10 Jan 2025	Purchase	3.47 Cr	₹362.11	95.87 K	Bulk	0.958651	NSE
10 Jan 2025	Purchase	2.38 Cr	₹367.89	64.56 K	Bulk	0.645617	NSE
10 Jan 2025	Purchase	1.93 Cr	₹374.42	51.55 K	Bulk	0.51547	NSE

Insider trading & SAST

Client name

Smita Goyal

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
10 Sep 2026	Promoter Group	Acquisition	0.01	0.6	3.34 L	₹334	1 K	09 Sep 2026	Market Purchase	57,344	Insider Trading	—	Equity
09 Sep 2026	Promoter Group	Acquisition	0.0085	0.59	2.72 L	₹320.47	850	08 Sep 2026	Market Purchase	56,144	Insider Trading	—	Equity
09 Sep 2026	Promoter Group	Acquisition	0.002	0.59	64.40 K	₹322	200	08 Sep 2026	Market Purchase	56,344	Insider Trading	—	Equity
29 Aug 2026	Promoter Group	Acquisition	0.01657	0.5	5.10 L	₹308.01	1.66 K	27 Aug 2026	Market Purchase	48,012	Insider Trading	—	Equity
29 Aug 2026	Promoter Group	Acquisition	0.066819	0.57	22.29 L	₹333.58	6.68 K	28 Aug 2026	Market Purchase	54,694	Insider Trading	—	Equity
29 Aug 2026	Promoter Group	Acquisition	0.006	0.58	2.02 L	₹335.97	600	28 Aug 2026	Market Purchase	55,294	Insider Trading	—	Equity
29 Aug 2026	Promoter Group	Acquisition	0.01035	0.49	3.13 L	₹302.64	1.03 K	26 Aug 2026	Market Purchase	46,355	Insider Trading	—	Equity
11 Aug 2026	Promoter Group	Acquisition	0.203546	0.28	63.28 L	₹310.88	20.36 K	27 Jul 2026	Market Purchase	27,137	Insider Trading	—	Equity
11 Aug 2026	Promoter Group	Acquisition	0.008	0.07	2.40 L	₹300.35	800	24 Jul 2026	Market Purchase	6,782	Insider Trading	—	Equity
11 Aug 2026	Promoter Group	Acquisition	0.026829	0.47	8.69 L	₹323.88	2.68 K	31 Jul 2026	Market Purchase	45,320	Insider Trading	—	Equity

Nureca Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Nureca Share Price

Nureca Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Nureca Share Price

Nureca Share Price

Oscillators

Moving averages

Nureca Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Nureca Share Price

Corporate Actions

Company details

Nureca Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Nureca Share Price

News

Nureca Limited Reports Q3 FY26 Profit of Rs 3.20 Crores, Revenue Up 46% YoY to Rs 39.60 Crores.

Nureca Limited Board to Discuss Share Buyback Proposal in Scheduled Meeting on 28th November 2025.

Nureca: Co Reports 87% Growth For Q4 Fy25, Expands Reach With Swiggy And Release Strategic Priorities For Fy 26

Nureca Ltd. - Quaterly Results

Nureca Ltd. reports Profit after tax of 2.07 Crores, in the March 2025 quarter

Nureca Ltd. - Quaterly Results

Nureca expands quick commerce reach with Dr Trust products now available on Swiggy Instamart

Nureca: Co Expands Quick Commerce Reach With Dr Trust Products Now Available On Swiggy Instamart

Nureca gains on getting nod to set up new manufacturing facility in Punjab

Nureca gets nod to set up new manufacturing facility in Punjab

Nureca: Co Gets Formal Approval For Setting Up Of Manufacturing Facility In Sundra, Punjab || New Unit To Manufacture Health And Wellness Equipment

Nureca’s manufacturing arm completes annual registration with USFDA

Nureca: Co’S Manufacturing Subsidiary Secures Us Fda Registration Nureca Technologies Pvt Ltd Expands Global Reach In Medical Devices

Nureca soars on getting nod to purchase land in India

Nureca gets nod to purchase land in India

Nureca informs about disclosure

Nureca Ltd. reports Profit after tax of Rs -3.29 Crores, in the December 2024 quarter

Nureca Ltd. - Quaterly Results

Nureca Ltd. - Quaterly Results

Nureca Ltd. - Quaterly Results

Nureca Ltd Share Price Today

Nureca Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator